Mesoblast Newsroom

Jefferies Downgrades Mesoblast to Hold From Buy; Price Target Is AU$2.30

MT NewswiresDec 23 17:06

Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $30

Futu NewsDec 21 21:33

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $15

Futu NewsDec 21 02:33

Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $30

Futu NewsDec 21 02:31

Mesoblast Is Maintained at Overweight by Piper Sandler

Dow JonesDec 20 01:53

Mesoblast Analyst Ratings

BenzingaDec 20 01:43

Piper Sandler Maintains Overweight on Mesoblast, Raises Price Target to $15

BenzingaDec 20 01:43

Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $18

Futu NewsNov 6 21:39

Buy Rating for Mesoblast Driven by Promising Market Opportunities and Upcoming PDUFA Date for Ryoncil

TipRanksNov 6 20:47

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $11

Futu NewsOct 31 19:31

Mesoblast Price Target Announced at $12.00/Share by Maxim Group

Dow JonesSep 24 21:13

Maxim Group Upgrades Mesoblast(MESO.US) to Buy Rating, Cuts Target Price to $12

Futu NewsSep 24 20:32

Bell Potter Sticks to Their Buy Rating for Mesoblast Limited (MEOBF)

TipRanksAug 30 10:10

Mesoblast Analyst Ratings

BenzingaAug 29 23:19

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Announces Target Price $11

Futu NewsAug 29 19:32

Mesoblast (MESO) Receives a Buy From Piper Sandler

TipRanksAug 29 18:52

Mesoblast Analyst Ratings

BenzingaJul 24 01:57

Piper Sandler Upgrades Mesoblast to Overweight, Raises Price Target to $11

BenzingaJul 24 01:57

Piper Sandler Upgrades Mesoblast(MESO.US) to Buy Rating

Futu NewsJul 24 01:32

Mesoblast Limited (MEOBF) Was Downgraded to a Hold Rating at Jefferies

TipRanksJul 18 20:23